Overview

Immune Restoration by Lipoic Acid in AIDS

Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the immunomodulatory and antiviral effects of the glutathione-restoring dithiol, alpha lipoic acid (ALA) in HIV-infected persons unresponsive to highly active antiretroviral treatment (HAART).
Phase:
Phase 2
Details
Lead Sponsor:
National Center for Complementary and Integrative Health (NCCIH)
Treatments:
Thioctic Acid